CMTR-CHEMTRAK FDA OK Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CMTR-CHEMTRAK FDA OK

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Art Baer who wrote (854)	8/13/1997 2:26:00 PM
From: William Presti	of 1172

Cholestrak sales are growing. From a historical point of view, I will concede your point that the product is not the success it was expected to be. If you notice, I did not describe sales as being a success either. But, at the same time, I would not say that the product is a total failure either. The claims of product performance were never overstated, only the predicted consumer market was. Why is the stock price in the basement? Revenues. Or lack of substantial revenues. Unfortunately, the price does not reflect future potential revenue growth anymore. That I attribute to loss of investor patience as well as a loss of interest in the whole rapid-testing market. Look at Quidel. They are growing sales, but that fact is not really reflected in their stock price either. Eventually, this market segment should come back into favor -- especially at these prices. Good luck. Hope you jump back in at some point. Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next